Investec Bank Plc has filed a Form 8.5 public dealing disclosure relating to Advanced Medical Solutions Group Plc (AMS.L), as required under Rule 8.5 of the Takeover Code.
The disclosure identifies Investec as an exempt principal trader acting in a client-serving capacity with recognised intermediary status during the relevant dealing period.
Investec holds a dual role in this matter, serving as both adviser and joint broker to Advanced Medical Solutions Group Plc throughout the offer process.
The dealings covered by the disclosure were undertaken on 4th September 2026, with the formal filing submitted to the market on 7th September 2026.
In terms of purchase activity, Investec Bank Plc bought 86,619 ordinary shares in Advanced Medical Solutions Group, with prices ranging from a low of 281.25p to a high of 281.5p per unit.
On the sales side, the bank disposed of 28,981 ordinary shares, with prices ranging between 218.5p and 281.25p per unit during the same dealing period.
No cash-settled derivative transactions were reported as part of this disclosure, with all relevant fields marked as not applicable by the filing party.
Similarly, no stock-settled derivative transactions, including options, were recorded, and no other dealings such as subscriptions or conversions were disclosed in the filing.
Investec confirmed that no indemnity or option arrangements exist, and no agreements or understandings relating to voting rights or future acquisitions tied to derivatives are in place.
The disclosure contact named in the filing is Abhishek Gawde, with a telephone number provided for any follow-up enquiries related to the submission.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be made to a recognised Regulatory Information Service to ensure market transparency.
The Panel’s Market Surveillance Unit remains available for consultation regarding dealing disclosure requirements under the Code for any parties seeking guidance.
